The world’s most popular fitness target originated as a 1965 Japanese marketing campaign. Six decades of research now point to a more forgiving and more achievable number.

She had been walking every morning for three years. The route was always the same: out the front door, around the lake, back up the hill, and home before her coffee got cold. On most days, she logged somewhere between 6,500 and 7,200 steps. Occasionally, she made it to 8,000. The little ring on her phone told her, day after day, that she had fallen short. The goal line was at 10,000, and she rarely reached it.

She was not failing at anything. But she had no way to know that, because for decades the number 10,000 has been presented, in fitness apps, on wearables, in workplace wellness programs, and in countless health articles, as if it were a clinical recommendation. It is not. It was never established by science. It was set by an advertising team.

A Pedometer, a Marketing Team, and a Number That Stuck

In 1965, a Japanese clock and instrument company called Yamasa Tokei Keiki released one of the first consumer pedometers. The timing was deliberate. The 1964 Tokyo Olympics had just ended, and there was wide public concern in Japan that ordinary citizens, watching world-class athletes compete, had been reminded of how little they moved. Yamasa saw a market.

The device was called the Manpo-kei. In Japanese, “man” means 10,000, “po” means steps, and “kei” means meter. The name was chosen, in part, because the Japanese character for 10,000 visually resembles a person mid-stride. It was catchy, easy to remember, and represented what the company felt was a challenging but reachable aspiration for the average person. There was no clinical trial behind it, no epidemiological study, no expert consensus. It was a product name.

The Manpo-kei sold well. Japanese walking clubs adopted the 10,000-step target. The concept spread internationally, was absorbed into public health messaging, and eventually became the default setting on virtually every fitness wearable and health app on the market. A marketing slogan had become a global health standard.

“A common goal of 10,000 steps per day has been perpetuated by the lay press and is often used as the default by software programs on wearables and smartphones. However, the origin of the goal of 10,000 steps per day is unclear.” — Dr. I-Min Lee, Harvard Medical School, JAMA Internal Medicine

What a Landmark Harvard Study Found

The first large-scale scientific investigation of the 10,000-step target in older adults produced results that upended the premise. In 2019, a team led by Dr. I-Min Lee, an epidemiologist in the Division of Preventive Medicine at Brigham and Women’s Hospital and Harvard Medical School, analyzed data from nearly 17,000 women with an average age of 72, drawn from the long-running Women’s Health Study. Participants wore research-grade accelerometers on their hips for seven consecutive days. The team then tracked deaths from any cause over a follow-up period averaging more than four years.

The findings, published in JAMA Internal Medicine, were striking. Women who walked approximately 4,400 steps per day had a 41% lower risk of death during the study period compared with those who walked only about 2,700. That benefit continued to grow as step counts rose, but it leveled off at around 7,500 steps per day. Beyond that point, taking more steps did not appear to reduce mortality risk further. The study authors noted directly that 10,000 daily steps had been “perpetuated by the lay press” without a clear scientific origin.

The stepping intensity, how fast the women were walking, did not appear to affect the mortality findings once total steps were accounted for.

The Evidence Has Since Grown Substantially

The Harvard study examined a specific population, older women, and a specific outcome: all-cause mortality. Since then, the scientific record on daily step counts has expanded considerably, with research now extending to both sexes, younger adults, and a range of health outcomes beyond death.

The most comprehensive synthesis to date was published in The Lancet Public Health in July 2025. Led by Professor Melody Ding from the University of Sydney School of Public Health, the analysis pooled data from 57 studies involving more than 160,000 adults across more than ten countries, including the United States, the United Kingdom, Australia, Japan, and Norway. Unlike earlier reviews focused mainly on mortality, this study examined how step counts relate to a wide range of outcomes: cardiovascular disease incidence and death, cancer, type 2 diabetes, dementia, depression, falls, and physical function.

The headline finding: walking approximately 7,000 steps per day was associated with meaningful reductions across nearly every outcome measured. Compared to taking only about 2,000 steps daily, 7,000 steps per day was linked with a 47% lower risk of all-cause mortality, a 25% lower risk of cardiovascular disease, a 38% lower risk of dementia, a 22% lower risk of depression, a 14% lower risk of type 2 diabetes, and a 28% lower risk of falls. For most of these outcomes, benefits began accruing at around 3,000 to 4,000 steps and plateaued near 7,000. Going from 7,000 to 10,000 added little additional benefit for most conditions, though for cardiovascular disease specifically, some benefit continued beyond 7,000.

A separate meta-analysis published in the European Journal of Preventive Cardiology in 2023, which analyzed 17 studies covering more than 226,000 participants, found that meaningful cardiovascular benefit began at just under 4,000 steps per day, less than half the canonical 10,000 target.

Why the Gap Between Science and Default Settings Persists

If multiple high-quality studies now point to 7,000, or even 4,000 to 5,000, as the threshold beyond which substantial health gains begin, why does every major wearable still default to 10,000?

Partly inertia. The 10,000 figure has been embedded in public health messaging for decades and in product defaults for years. Changing it would require manufacturers to actively reconfigure software and risk confusing users accustomed to the old goal. Partly, the figure functions as motivational headroom: if 7,000 is the threshold where benefits plateau for mortality, 10,000 could be seen as a buffer that keeps even the irregular walker within a meaningful range. And for younger, more active adults, the Lancet data suggest benefits for some outcomes continue rising toward and beyond 10,000.

But for older adults, the primary demographic of the Wellness Letter and the group for whom the evidence is clearest, the practical message is meaningfully different. A 70-year-old who manages 5,500 steps on most days is not falling short. She is, by every measure the research supports, capturing the substantial majority of the health benefit that walking can provide.

The Risks of an Unachievable Target

Setting targets that most sedentary or older people cannot reasonably reach has a well-documented downside: it discourages the very people most likely to benefit from any increase in movement. Research in behavioral science and public health consistently shows that unachievable goals promote disengagement rather than effort. A person who walks 4,000 steps and sees a persistent “goal not reached” message on her device may conclude that what she is doing is pointless, and stop tracking, or stop walking entirely.

The Lancet study authors specifically addressed this, noting that 7,000 steps “might be a more realistic and achievable target for some”, a deliberate acknowledgment that the scientific story is not just about cardiovascular risk reduction but about what goals actually change behavior at the population level. The science points in the same direction: even 1,000 steps more than your current average, sustained over time, is associated with measurable health gains. Movement is not all-or-nothing.

What This Means in Practice

Public health guidelines in the United States and most high-income countries still focus primarily on minutes of moderate-intensity exercise per week rather than step counts, because the evidence base for time-based recommendations is older and more developed. The U.S. Physical Activity Guidelines recommend 150 minutes of moderate-intensity aerobic activity per week for most adults, a target that, for walking, translates to roughly 7,000 to 8,000 steps per day for someone covering that time at a brisk pace.

The convergence of these estimates is notable. Step-count research and traditional exercise physiology are now pointing to a similar zone of meaningful benefit, well below 10,000. What remains unclear from the existing research is whether step intensity independently matters once total steps are controlled for, whether the findings generalize equally across racial and ethnic groups (most studies have skewed toward white populations), and whether the relationships hold in the setting of specific chronic conditions. The Lancet authors rated the certainty of evidence as moderate for all-cause mortality and cardiovascular disease incidence, and lower for several other outcomes.

For the moment, the most useful thing a person can do with this evidence is not change their goal to exactly 7,000 and stop there, but rather understand that the threshold for health benefit is lower than the cultural narrative suggests, and that the greatest gains from walking are captured in the move from very little activity to modest activity, not in the push from 8,000 to 10,000.

Bottom Line

Evidence strength: Moderate to strong, large meta-analyses including Lancet Public Health 2025; limitations include observational design, residual confounding, and limited age-stratified data

The 10,000-step daily target was not derived from clinical research. It originated as a 1965 Japanese marketing name. The best available evidence, including a 2025 meta-analysis of 57 studies in The Lancet Public Health, indicates that meaningful health benefits begin at roughly 4,000 steps per day and that most outcomes plateau at around 7,000 for many adults. For older adults in particular, achieving 5,000 to 7,500 steps per day appears to capture the substantial majority of the mortality and chronic disease benefit that daily walking can confer.

If 10,000 is a comfortable and motivating goal for you, there is no reason to lower it; some evidence suggests continued benefit for cardiovascular outcomes at higher step counts. But if you regularly fall short of 10,000 and feel discouraged by it, the research supports a recalibration: any increase from your current baseline is likely to carry real health value, and the gap between 5,000 and 7,000 steps is far more meaningful than the gap between 7,000 and 10,000.